magnifying glass
logo for Poxel

Poxel

Healthcare Services · France · 55 Employees

Get Full Access

Who is Poxel

Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. Poxel S.A. was incorporated in 2009 and is headquartered in Lyon, France.Read More

Headquarters

Headquarters:

259-261 Ave Jean Jaurès, Lyon, Auvergne-Rhone-Alpes, 69007, France
Phone Number

Phone Number:

+33 437372010
Revenue

Revenue:

$14 Million
Poxel's Social Media
SIC Code 28,283
NAICS Code 32,325
Ticker PXXLF
Popular Searches:

Poxel

Poxel Inc

Poxel SA

""

Poxel's Org Chart

PhonePhoneEmailEmail
Takashi Kaneko
Takashi Kaneko

Senior VP, Medical & President

PhonePhoneEmailEmail

PhonePhoneEmailEmail

PhonePhoneEmailEmail
Illustration of an envelope

Poxel Company Metrics

Company Insights
Employee Growth Rate
Funding
Funding DateRoundAmountInvestors

Aug 08, 2022

Debt

$6M

IRIS

Oct 15, 2020

Unspecified

$7M

BNP Paribas

May 26, 2020

Share Placement

$19M

Undisclosed

See More

$67M

Total Funding Amount

$6M

Most Recent Funding Amount

5

Number of Funding Rounds

Poxel's Tech Stack

Modernizr

By

Modernizr

DocuSign

By

DocuSign

Google Font API

By

Google

Google Universal Analytics

By

Google
See more technologies

Poxel News & Media

Poxel Announces Positive Histology Results from Phase 2 NASH Trial (DESTINY-1) for PXL065, a Novel, Proprietary Deuterium-Stabilized R-stereoisomer of Pioglitazone

LYON, France--(BUSINESS WIRE)--POXEL SA (Euronext : POXEL - FR0012432516), clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today announced positive histology results for DESTINY-1 (Deuterium-stabilized R-pioglitazone [PXL065] Efficacy and Safety Trial In NASH), the dose-ranging Phase 2 trial of PXL065 for the treatment of NASH. PXL06

Poxel Reports Financial Results for First Half 2022 and Provides a Corporate Update

LYON, France--(BUSINESS WIRE)--POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today announced its financial results for the period ended June 30, 2022 and provided a corporate update. Thomas Kuhn, Chief Executive Officer of Poxel, stated: “Thus far, 2022 has been marked by important achie

Poxel Announces Positive Results from Phase 2 NASH Trial (DESTINY-1) for PXL065, A Novel, Proprietary Deuterium-Stabilized R-Stereoisomer of Pioglitazone

LYON, France--(BUSINESS WIRE)--POXEL SA (Euronext : POXEL - FR0012432516), clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today announced positive top-line results for DESTINY-1 (Deuterium-stabilized R-pioglitazone [PXL065] Efficacy and Safety Trial In NASH), the dose-ranging Phase 2 trial of PXL065 for the treatment of NASH. PXL065
Subscribe to "Poxel" News

Frequently Asked Questions regarding Poxel

Where are Poxel’s headquarters?

Poxel’s headquarters are in 259-261 Ave Jean Jaurès, Lyon, Auvergne-Rhone-Alpes, 69007, France

What is Poxel’s phone number?

Poxel’s phone number is +33 437372010

What is Poxel’s official website?

Poxel’s official website is www.poxelpharma.com

What is Poxel’s Revenue?

Poxel’s revenue is $14 Million

What is Poxel’s SIC code?

Poxel’s SIC: 28,283

What is Poxel’s NAICS code?

Poxel’s NAICS: 32,325

How many employees are working in Poxel?

Poxel has 55 employees

What is Poxel’s industry?

Poxel is in the industry of: Healthcare Services, Manufacturing, Medical Laboratories & Imaging Centers

What is Poxel's tech stack?

The technologies that are used by Poxel are: Modernizr, DocuSign, Google Font API, Google Universal Analytics

See more information about Poxel
4.4/5 on G2 Crowd